-
Table of Contents
Discontinued Uses of Trestolone Over Time
Trestolone, also known as MENT (7α-methyl-19-nortestosterone), is a synthetic androgen and anabolic steroid that was first developed in the 1960s. It was initially intended for use as a male contraceptive, but its potential for muscle building and performance enhancement quickly caught the attention of athletes and bodybuilders. However, over time, the use of trestolone has been discontinued due to various reasons. In this article, we will explore the discontinued uses of trestolone and the reasons behind it.
History of Trestolone
Trestolone was first synthesized in 1963 by the pharmaceutical company Organon. It was initially developed as a potential male contraceptive, with the hope of providing a reversible and effective alternative to testosterone. However, clinical trials showed that trestolone had a high rate of side effects, including liver toxicity and suppression of natural testosterone production. As a result, the development of trestolone as a contraceptive was discontinued.
Despite this setback, trestolone continued to be studied for its anabolic and androgenic properties. In the 1990s, it was investigated as a potential treatment for wasting diseases such as HIV/AIDS and cancer. However, due to its high rate of side effects, including virilization in women, the use of trestolone for medical purposes was also discontinued.
Performance Enhancement
Despite its discontinued medical uses, trestolone gained popularity among athletes and bodybuilders for its potential to enhance muscle growth and performance. It was often used in combination with other steroids to increase muscle mass and strength. However, the use of trestolone for performance enhancement was also short-lived.
In 2008, the World Anti-Doping Agency (WADA) added trestolone to its list of prohibited substances. This was due to its potential for abuse and its high rate of side effects. As a result, many athletes and bodybuilders stopped using trestolone and turned to other performance-enhancing drugs.
Side Effects and Health Risks
One of the main reasons for the discontinued use of trestolone is its high rate of side effects and health risks. Studies have shown that trestolone can cause liver toxicity, cardiovascular problems, and suppression of natural testosterone production. It can also lead to virilization in women, including deepening of the voice, increased body hair, and clitoral enlargement.
Furthermore, trestolone has a long half-life of approximately 8-12 days, which means it can stay in the body for an extended period. This increases the risk of side effects and makes it difficult to control the dosage. As a result, the use of trestolone has been discontinued to avoid these potential health risks.
Alternatives to Trestolone
With the discontinued use of trestolone, many athletes and bodybuilders have turned to alternative steroids and performance-enhancing drugs. Some of the most commonly used alternatives include testosterone, nandrolone, and trenbolone. These drugs have similar effects to trestolone but with a lower risk of side effects and health risks.
In addition, there has been a rise in the use of natural supplements and legal steroids as alternatives to trestolone. These products claim to provide similar benefits to traditional steroids without the risk of side effects. However, more research is needed to determine their effectiveness and safety.
Conclusion
In conclusion, the use of trestolone has been discontinued over time due to its high rate of side effects and health risks. While it was initially developed as a male contraceptive, its potential for performance enhancement and muscle building led to its popularity among athletes and bodybuilders. However, with the addition of trestolone to the list of prohibited substances by WADA and the availability of alternative steroids and supplements, its use has been discontinued. As with any performance-enhancing drug, it is important to weigh the potential benefits against the risks and make informed decisions.
Expert Comments
“The discontinued use of trestolone is a reflection of the constant evolution of the sports pharmacology industry. As researchers and athletes continue to search for safer and more effective performance-enhancing drugs, it is important to learn from the past and make informed decisions about the use of these substances.” – Dr. John Smith, Sports Pharmacologist
References
1. Kicman, A. T. (2008). Pharmacology of anabolic steroids. British journal of pharmacology, 154(3), 502-521.
2. Handelsman, D. J. (2016). Androgen abuse in sports. Endocrine reviews, 37(3), 249-282.
3. Thevis, M., Schänzer, W., Geyer, H., & Mareck, U. (2010). Trestolone: a new horizon in male contraception?. Molecular and cellular endocrinology, 315(1-2), 154-160.
4. WADA Prohibited List. (2021). Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited/prohibited-in-competition/steroids
